HOME >> BIOLOGY >> NEWS
Protein discovered that keeps hemoglobin in balance

Hematology researchers at The Childrens Hospital of Philadelphia have discovered a gene and its associated protein that may have major implications for red blood cell formation, specifically for hemoglobin, which carries oxygen in red blood cells. Understanding how this protein functions may eventually lead to novel treatments for the hemoglobin-related blood disease, thalassemia.

Thalassemia is a group of related inherited disorders that together are the most common single-gene disease known. The most severe form of the disease, beta thalassemia major, affects 300,000 patients worldwide.

Thalassemia results from an imbalance between two proteins in hemoglobin, called alpha and beta globin. An excess of either type of protein is toxic, causing thalassemia symptoms including poor growth, fatigue, bone damage, or skin ulcers. The newly found protein, alpha hemoglobin stabilizing protein (AHSP), binds to free alpha globin and prevents it from forming a precipitate that damages red blood cells.

AHSP acts as a chaperone molecule a chemical that helps another protein to fold or unfold, said Mitchell Weiss, M.D., Ph.D., a pediatric hematologist at The Childrens Hospital of Philadelphia, and senior author of the paper, published in the June 13 issue of Nature. Here it makes free alpha globin stable and prevents its deleterious effects.

Dr. Weiss team suspected that AHSP, by preventing free alpha hemoglobin from precipitating within red blood cells, protects the cells from injury. To test that hypothesis, the researchers developed knockout mice, animals genetically engineered to lack the gene that produces AHSP. Those mice showed blood abnormalities similar to those found in mice with thalassemia.

AHSPs protective role could explain how some patients who carry the genetic trait for beta thalassemia have mild disease and few symptoms even though their bodies produce more alpha than beta globin. By binding to free alpha globin, AHSP ma
'"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
215-590-7332
Children's Hospital of Philadelphia
12-Jun-2002


Page: 1 2

Related biology news :

1. Protein is key to fatal disorder and normal cell function
2. Protein is key for digestive function of the pancreas
3. Proteins show promise for mosquito control
4. Protein involved in childhood disorder linked to cancer
5. Protein fishing in America: The movie
6. Protein vaccine fully protects mice from lethal aerosol challenge with ricin toxin
7. Protein key to trafficking in nerve terminals
8. Protein controls acid in cells by direct detection of volume changes, study finds
9. Protein believed to control formation of memory identified by Scripps & UCSD scientists
10. Protein stops blood-vessel growth, holds promise as cancer therapy
11. Proteins transform DNA into molecular velcro

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/1/2019)... FRANCISCO (PRWEB) , ... April 01, 2019 , ... ... “Method and System for Characterizing Skin Related Conditions” by the US Patent and ... 2014. The patent is an invention by uBiome collaborators Dr. Zachary Apte, ...
(Date:3/29/2019)... ... March 28, 2019 , ... In the wake of the ... dedicated to Chinese biobanks was launched in July 2018, in an agreement between ... Branch, China Medicinal Biotech Association (BBCMBA). The one-year pilot programme offered two testing ...
(Date:3/29/2019)... ... March 29, 2019 , ... GenCure has selected G-CON ... therapy facility. The new facility, which will anchor the VelocityTX innovation center in ... art manufacturing capabilities to support clinical cell therapy trials. GenCure is a subsidiary ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... ... April 09, 2019 , ... To support the global ... Zuckerberg Biohub (CZ Biohub) has chosen Geneious Biologics to help them analyze and ... Biohub’s efforts to establish new approaches to inform the discovery of antibody-based diagnostics, ...
(Date:4/4/2019)... ... April 03, 2019 , ... ... intimate off-the-record collaboration and dialogue, today announces its Boston CEO conference to be ... into the industry’s challenges and opportunities with high-level panels and discussions from past, ...
(Date:3/27/2019)... ... , ... A leader in the field of Regenerative Veterinary Medicine, VetStem Biopharma ... and Canada since 2004. The primary indications for VetStem Regenerative Cell Therapy are ... cat, and horse. Recently, VetStem teamed up with the world-renowned San Diego Zoo ...
(Date:3/27/2019)... ... ... Lachman is sponsoring the event on April 1-4, where they will be located ... on site will be available to discuss strategies and tactics to support Facilities of ... Executives from Lachman participating at this year’s conference include Fran Zipp, President & CEO, ...
Breaking Biology Technology:
Cached News: